This is a public record generated listing.
Assets of Pharmaceutical Company
Listing Information
Attachments
Assets of Pharmaceutical Company
Price: Not Specified
Other Item Info
Item #: debke_177019
Created: 07/03/2019
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Mon. Aug 5, 2019
Created: 07/03/2019
Category: Business Property > All Assets or Going Concerns > Pharmaceuticals & Biotechnology
Sale Location: New York, New York
Sale Date: Mon. Aug 5, 2019
Seller Info
Mark D. Collins
Debtor's Attorney
One Rodney Square 920 North King Street
Wilmington, DE 19801
302 651-7700
Debtor's Attorney
One Rodney Square 920 North King Street
Wilmington, DE 19801
302 651-7700
Bankruptcy Info
Case #: 1:19-bk-11292
Case Title: Insys Therapeutics, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Case Title: Insys Therapeutics, Inc.
Court: Delaware Bankruptcy Court
Chapter: 11
View Case Docket
Description
Auction Sale of assets of Insys Therapeutics, Inc. related to each of (i) Subsys, (ii) SYNDROS® (“Syndros”) and other assets related to Cannabidiol Oral Solution, a synthetic cannabidiol (“CBD”), (iii) the seller;s epinephrine nasal spray product candidate (“Epinephrine”), (iv) the seller's naloxone nasal spray product candidate (“Naloxone”), (v) the seller's buprenorphine sublingual spray (“Buprenorphine,” and collectively with assets related to Subsys, Syndros, CBD, Epinephrine, and Naloxone, the “Assets”).
Financial Overview
Income and Expenses ($)
months
Revenue/Gross Income:
Total Expenses:
Cash Flow:
Asset and Liability Summary ($)
Receivables:
Inventory:
FF&E:
Real Estate:
Total Assets:
Liabilities to assume:
Additional Details
- Auction Time: 10:00 a.m.
- Sale Hearing Held on August 22, 2019, at 2:00 p.m.
- Bid Deposit: 5% of the proposed purchase price
- Bid Deadline: July 23, 2019
- Last date to respond: August 14, 2019